. Enhanced pyruvate dehydrogenase activity does not affect muscle O2 uptake at onset of intense exercise in humans. Am J Physiol Regulatory Integrative Comp Physiol 282: R273-R280, 2002.-It has been proposed that the activation state of pyruvate dehydrogenase (PDH) may influence the rate of skeletal muscle O2 uptake during the initial phase of exercise; however, this has not been directly tested in humans. To remedy this, we used dichloroacetate (DCA) infusion to increase the active form of PDH (PDHa) and, subsequently, measured leg O2 uptake and markers of anaerobic ATP provision during conditions of intense dynamic exercise, when the rate of muscle O2 uptake would be very high. Six subjects performed brief bouts of one-legged knee-extensor exercise at ϳ110% of thigh peak O2 uptake (65.3 Ϯ 3.7 W) on several occasions: under noninfused control (Con) and DCA-supplemented conditions. Needle biopsy samples from the vastus lateralis muscle were obtained at rest and after 5 s, 15 s, and 3 min of exercise during both experimental conditions. In addition, thigh blood flow and femoral arteriovenous differences for O2 and lactate were measured repeatedly during the 3-min work bouts (Con and DCA) to calculate thigh O2 uptake and lactate release. After DCA administration, PDHa was four-to eightfold higher (P Ͻ 0.05) than Con at rest, and PDHa remained ϳ130% and 100% higher (P Ͻ 0.05) after 5 and 15 s of exercise, respectively. There was no difference between trials after 3 min. Despite the marked difference in PDHa between trials at rest and during the initial phase of exercise, thigh O2 uptake was the same. In addition, muscle phosphocreatine utilization and lactate production were similar after 5 s, 15 s, and 3 min of exercise in DCA and Con. The present findings demonstrate that increasing PDH a does not alter muscle O2 uptake and anaerobic ATP provision during the initial phase of intense dynamic knee-extensor exercise in humans. blood flow; lactate; creatine phosphate; dichloroacetate ALTHOUGH THE MECHANISMS RESPONSIBLE for the delay in muscle O 2 uptake at the onset of exercise remain controversial (for review see Ref. 25), recent studies have suggested that this phenomenon is not due to limited O 2 availability but, rather, the ability of the muscle cells to utilize O 2 (3, 9-11). One mechanism potentially involved in a local limitation to O 2 uptake is "delayed" activation of the enzyme pyruvate dehydrogenase (PDH). PDH is considered rate limiting for pyruvate oxidation in skeletal muscle, and its activity is subject to strict regulatory control. The active form of PDH (PDH a ) and PDH flux must be kept low in resting muscle to prevent unnecessary carbohydrate utilization and flux through the enzyme must be rapidly accelerated during strenuous exercise to meet the increased demand for carbohydrate-derived acetyl-CoA (14). A possible role for PDH in regulating muscle O 2 uptake has been suggested by several recent studies that employed the pharmacological agent dichloroacetate (DCA). DCA administration was shown to markedly increase PDH a in skeletal muscle and attenuate markers of anaerobic ATP provision during electrically evoked contractions in animals and during submaximal exercise in humans (12, (22) (23) (24) . For example, Timmons et al. (22) reported that pretreatment with DCA resulted in a ϳ50% reduction in muscle phosphocreatine utilization during 8 min of knee-extensor exercise at an intensity of ϳ45% of leg peak O 2 uptake (V O 2 peak ). This observation was confirmed by Howlett and colleagues (12), who showed that DCA infusion attenuated muscle degradation after 30 s of exercise and lactate accumulation after 2 min of submaximal cycle exercise at ϳ65% of maximal O 2 uptake (V O 2 max ). It was hypothesized that the availability of acetyl groups to the tricarboxylic acid (TCA) cycle, which is increased after PDH activation by DCA, is a key determinant of muscle O 2 uptake at the start of exercise (22, 23). To our knowledge, however, there have been no direct measurements of muscle O 2 uptake during exercise after DCA administration in humans.
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Thus the aim of the present study was to determine whether manipulation of PDH a would alter muscle O 2 uptake or markers of anaerobic ATP provision during the initial phase of intense exercise in humans (i.e., when the rate of muscle O 2 uptake would be high and pyruvate is the primary source for the citric acid cycle). To examine this issue, subjects performed intense dynamic knee-extensor exercise on several occasions: un-der noninfused control (Con) and DCA-supplemented conditions.
METHODS

Subjects.
Six healthy men, ranging in age from 21 to 24 yr, with an average height of 178 (range 172-183) cm and a mean body mass of 72.5 (range 67.9-78.3) kg, participated in the experiment. The subjects were fully informed in advance of the risks and discomfort associated with the experimental procedures, and all provided written consent. The study was approved by the Ethics Committee of Frederiksberg and Copenhagen.
Experimental protocol. Subjects were instructed to consume a light breakfast ϳ3 h before an experimental trial. After the subjects reported to the laboratory and rested in the supine position for ϳ30 min, a catheter was inserted into a femoral artery under local anesthesia. The tip was positioned 1-2 cm proximal to the inguinal ligament. A catheter was also inserted into the femoral vein of the leg to be exercised, ϳ1-2 cm distal to the inguinal ligament. A thermistor for measurement of venous blood temperature was inserted through the catheter and advanced 8-10 cm proximal to the tip.
At ϳ1 h after insertion of the catheters, subjects performed a 3-min bout of dynamic knee-extensor exercise in the supine position on an ergometer that permitted the exercise to be confined to the quadriceps muscle (1). The external power output was 65.3 Ϯ 3.7 W, corresponding to ϳ110% of thigh V O2 peak, and the kicking frequency was 60 rpm. At this work intensity, subjects would typically have been exhausted after ϳ4 min. Just before exercise, the leg was passively moved for 5 s to accelerate the flywheel. Blood was drawn from the femoral artery and vein ϳ10 and 5 s before the exercise and ϳ2, 6, 10, 14, 29, 45, 60, 90, 120, 145, and 165 s during exercise. In addition, femoral venous blood flow was measured by the thermodilution technique (2) approximately every 30 s after ϳ1 min of the first exercise bout as well as ϳ3 s before and after 5, 35, 60, 90 and 160 s of exercise when the exercise bout was repeated after 1 h of rest. Values of blood flow obtained at the same time during the first exercise bouts agreed with the values after 60 min of rest for Con (4.36 Ϯ 0.30 vs. 4.45 Ϯ 0.23 l/min after 67 s, 4.83 Ϯ 0.46 vs. 5.13 Ϯ 0.44 l/min after 99 s, and 5.63 Ϯ 0.70 vs. 5.39 Ϯ 0.58 l/min after 152 s) and DCA (4.32 Ϯ 0.48 vs. 4.58 Ϯ 0.23 l/min after 67 s and 5.77 Ϯ 0.50 vs. 5.48 Ϯ 0.54 l/min after 166 s) with a coefficient of variation (CV) of 5.4%. Thus, in Con and DCA, the blood flow values after the rest period were used in the calculations. An occlusion cuff placed just below the knee was inflated (220 mmHg) during the exercise to avoid blood contribution from the lower leg. A needle biopsy sample was obtained from the vastus lateralis muscle under local anesthesia before and after each of the exercise bouts.
The exercise protocol was performed on two occasions separated by ϳ14 days. On one occasion, DCA (sodium salt, pH 7.0, 50 mg/kg body mass) was infused (50 mg/ml) into the femoral vein over a 30-min period, ending 10 min before the start of exercise (DCA). On the other occasion, no infusion was performed (Con). The same leg was exercising in the Con and DCA experiments, which were performed in a counterbalanced order.
In addition, on two separate occasions within 3 wk of the main experiments, subjects performed knee-extensor exercise at the same work intensity for 5 and 15 s, separated by a 45-min rest period, under Con and DCA-supplemented conditions. A muscle biopsy from the vastus lateralis muscle was obtained before and after the 5-s exercise bout and after the 15-s work bout. For the DCA-supplemented trial, subjects received an extra dose of 25 mg/kg body mass between bouts, 15 min before the start of the 15-s exercise bout. Thus, in total, two needle biopsy samples were obtained at rest, and single samples were obtained after 5 s, 15 s, and 3 min of exercise for the DCA and Con conditions. There were no differences between the two rest biopsies within a given condition with regard to metabolite concentrations or enzyme activity, and data for all biopsy samples are presented.
Blood analyses. O 2 saturation of blood and hemoglobin concentration were determined spectrophotometrically (Radiometer OSM-3 hemoximeter). The hemoximeter was calibrated using the cyanmethemoglobin method (6) . Hematocrit was determined in triplicate using microcentrifugation. A 100-l aliquot of each blood sample was hemolyzed within 10 s of sampling using a 1:1 dilution with a buffer solution (Yellow Spring Instruments, Yellow Springs, OH), to which Triton X-100 (20 g/l) was added to determine lactate (YSI 23 lactate analyzer, Yellow Spring Instruments) (7). The remainder of the blood sample was placed in ice-cold water and centrifuged rapidly for 30 s. From this sample, plasma was collected and stored at Ϫ80°C until subsequent analysis for pyruvate using a fluorometric assay (15) .
Muscle analyses. Needle biopsy samples were immediately frozen in liquid nitrogen and stored at Ϫ80°C. A 20-to 30-mg piece was removed from each biopsy and used to determine PDH a using the method of Constantin-Teodosiu et al. (5) as modified and described by Putman et al. (20) . The remainder of the frozen muscle sample was weighed before and after it was freeze-dried to determine water content. After the sample was freeze-dried, it was dissected free of blood and connective tissue, and the muscle tissue was extracted in a solution of 0.6 M perchloric acid and 1 mM EDTA, neutralized to pH 7.0 with 2.2 M KHCO3, and stored at Ϫ80°C. Muscle extracts were subsequently analyzed for creatine phosphate and lactate using fluorometry (15) .
Muscle mass. The mass of the quadriceps femoris muscle group was estimated using magnetic resonance imaging. Briefly, for each subject, 30-33 parallel axial T1-weighted images (sections) of the right thigh were obtained with a multislice spin-echo FLASH sequence (TR ϭ 500 ms, TE ϭ 15 ms) using a body coil. Slice thickness was 3 mm, with a gap of 12 mm between each slice. Pixel size was 1.2 mm 2 . This setting was selected to optimize image quality and clearly separate muscle, bone, fat, and connective tissue. Image analyses were performed using NIH Image software. The mean knee-extensor mass of the experimental leg was 2.35 kg (range 1.94-2.79 kg).
Calculations. The uptake/release of O2 and lactate across the thigh was calculated by multiplying the blood flow by the femoral arteriovenous difference in O2 content and lactate concentration, respectively. Pyruvate exchange was calculated in a similar manner, except leg plasma flow was used. A continuous blood flow curve was constructed for each subject using a linear connection of consecutive data points to obtain time-matched values for blood flow and blood measurements. Lactate production during exercise was calculated as the sum of muscle lactate accumulation and total lactate release, determined as the area under the lactate release curve, expressed per unit active muscle.
To determine the mean transit time (MTT) of the blood from the femoral artery to the collecting site in the femoral vein, four of the subjects performed the main experimental protocol a third time on a separate occasion (without DCA infusion), as described previously (3) . Briefly, the experimental conditions and position of the catheters were the same as in the main experiments. Before and frequently during the exercise, indocyanine green dye (Cardiogreen, Becton Dickinson) was injected rapidly into the femoral artery, and immediately thereafter the artery was flushed with isotonic saline. Blood was withdrawn from the femoral vein for measurements of dye concentration using a linear densitometer, and MTT was detected as the time from injection to the time when the curve peaked, corrected by transit time of catheter. The MTT values for Con were used to make calculations during the DCA experiment. This assumption appears valid, since no differences in thigh blood flow during exercise were observed between Con and DCA (see above). On the basis of MTT, the average time to which the collected artery and venous blood represented capillary blood was estimated as described previously (3) . All blood variables are presented in relation to mean time at the capillary. For the two subjects where no MTT values were obtained, average values were used.
Statistics. Data were analyzed using two-way analysis of variance with repeated measures. A significance level of 0.05 was chosen. If a significant interaction was detected, data were subsequently analyzed using a Newman-Keuls post hoc test. Unless otherwise noted, values are means Ϯ SE.
RESULTS
Muscle PDH. In Con muscle, PDH a at rest was ϳ10% of PDH a at the end of the 3-min exercise bout, and it increased to 28 and 38% after 5 and 15 s, respectively (Table 1) . Compared with Con, DCA infusion elevated (P Ͻ 0.05) PDH a by four-to eightfold at rest (Table 1) , by 130 and 100% after 5 and 15 s of exercise, respectively, but no difference was observed at the end of exercise (Fig. 1) .
Thigh O 2 uptake. In Con and DCA, thigh blood flow increased from ϳ1.7 l/min just before exercise to 5.4 l/min at the end of exercise (Fig. 2) .
Arterial O 2 content increased (P Ͻ 0.05) from ϳ189 to 200 ml/l during Con and DCA. Femoral venous O 2 content was the same before Con and DCA (ϳ170 ml/l) and decreased in a similar manner during Con and DCA, reaching 55 ml/l at the end of exercise. Correspondingly, arteriovenous O 2 and leg O 2 uptake before and during exercise were the same in Con and DCA (Fig. 3) .
Muscle creatine phosphate. Muscle creatine phosphate decreased by ϳ15 and 25% during the first 5 and 15 s of exercise, respectively, reaching a level corresponding to 30% of rest (24 mmol/kg dry wt) at the end of exercise in Con and DCA (Table 1) . Consequently, the average rates of creatine phosphate degradation were the same in Con and DCA (Fig. 4) .
Thigh pyruvate exchange. In DCA, arterial and venous pyruvate were lower (P Ͻ 0.05) than in Con before and throughout exercise (Fig. 5A ). After 90 s of exercise, pyruvate release was higher (P Ͻ 0.05) in DCA than in Con (Fig. 5B) .
Lactate production. No differences between Con and DCA were observed in the increase of muscle lactate in the first 5 and 15 s of exercise or in the last phase of exercise, with the total increase during exercise being ϳ80 mmol/kg dry wt in Con and DCA (Table 1) . Arterial lactate was lower (P Ͻ 0.05) in DCA than in Con Values are means Ϯ SE. PDHa, active fraction of pyruvate dehydrogenase; Con, control; DCA, dichloroacetate. * Significantly different from Con. † Significantly different from preexercise. before and throughout exercise, and femoral venous lactate was lower (P Ͻ 0.05) before and during the first 14 s of exercise (Fig. 6A) . In DCA, net lactate release was higher (P Ͻ 0.05) after 30 s of exercise and toward the end of exercise than in Con (Fig. 6B ). The average rates of lactate production were the same in Con and DCA (Fig. 7) .
DISCUSSION
The major findings from the present study were that although DCA infusion increased PDH a at rest and during the first 15 s of intense exercise compared with the control condition, muscle O 2 uptake, creatine phosphate degradation, and lactate production were not affected. These observations suggest that the delayed muscle respiratory response during the initial phase of intense dynamic exercise in humans (ϳ110% of thigh V O 2 peak ) is not due to a lag in PDH activation.
Under control conditions, PDH a after 15 s of exercise was only about one-third of that at the end of 3 min of work, at which time the enzyme was likely fully converted to the active form (19) . Few data are available regarding the time course for PDH activation during the initial seconds of exercise. However, Parolin et al. (16) reported that PDH increased from 14% active at rest to 48% after 6 s of maximal isokinetic cycling and was almost totally activated by 15 s. In addition, Howlett et al. (13) recently reported a 65% transformation of PDH to the active form after 10 s of maximal sprint cycling. The slower activation in the present study than in these previous two studies may be related to exercise intensity, e.g., maximal cycling (Ͼ300% of the intensity eliciting V O 2 max ) vs. the power output (ϳ110% of thigh V O 2 peak ) in the present study, which was sustained for 3 min. Although a number of mechanisms could be involved, one potential factor is difference in mitochondrial Ca 2ϩ released from the sarcoplasmic reticulum, which is believed to be important for the initial activation of PDH during contraction (26). The observations that PDH was only partly activated and that there was a significant accumulation of muscle lactate after 5 and 15 s of exercise indicate that the rate of pyruvate production from glycolysis was in excess of mitochondrial pyruvate oxidation and could be interpreted to suggest that flux through PDH was limiting for O 2 uptake at the start of exercise. However, we did not observe any elevation in the rate of muscle O 2 uptake after DCA administration, despite the fact that this manipulation markedly increased PDH a at rest as well as after 5 and 15 s of exercise compared with the control trial. It should be considered whether the measurements of leg O 2 uptake are sensitive enough to detect a possible difference in O 2 uptake. The average thigh blood flow in the initial phase of exercise was the same in Con and DCA, but the individual differences between Con and DCA were greater in the 1st min (CV ϭ 12%) than in the last 2 min (CV ϭ 6%). However, because thigh blood flow also was the same in Con and DCA just before and during the remaining part of exercise, it seems unlikely that blood flow in Con and DCA was different in the early phase of exercise. Some variation in arteriovenous O 2 difference was also observed in the 1st min of exercise (CV ϭ 14%) and less during the last 2 min (CV ϭ 3%). However, there was not even a tendency for the O 2 extraction to be higher in DCA, since half of the subjects had higher arteriovenous O 2 difference values in the first phase of exercise in Con than in DCA. In another knee-extensor study, a measurably higher O 2 extraction (Ͻ20 ml/l) was observed after a few seconds of repeated exercise (4) . Thus the lack of difference in arteriovenous O 2 difference and thigh O 2 uptake between Con and DCA appears not to be caused by the measurement of O 2 extraction and blood flow not being sensitive enough. Moreover, the DCA treatment did not change the rate of creatine phosphate degradation or lactate production in the exercising muscles, indicating that the anaerobic ATP provision was not changed with DCA infusion. Thus these data suggest that the activation state of PDH does not limit mitochondrial respiration during the initial phase of in- tense (ϳ110% V O 2 peak ) dynamic knee-extensor exercise in humans.
Although the effect of DCA infusion on muscle O 2 uptake has not been studied previously, a number of recent investigations have examined the effect of DCA administration on skeletal muscle anaerobic metabolism in animals and humans. When PDH in resting canine gracilis muscle was activated by pretreatment with DCA, the estimated anaerobic energy contribution during electrically induced contraction was reduced, suggesting an increased aerobic contribution (24) . In a human study conducted by the same group of investigators (22) , a threefold increase in resting muscle PDH activity and a fivefold increase in muscle acetylcarnitine were observed after DCA infusion. During a subsequent bout of one-legged knee-extensor exercise, muscle creatine phosphate was significantly higher (30%) after 8 min of contraction than in a control situation; however, there were no differences between conditions in muscle lactate. In another human study using partial ischemia, Timmons et al. (23) observed that DCA infusion reduced creatine phosphate degradation and muscle lactate accumulation by ϳ50% after 3 min of submaximal, single-leg kneeextension exercise, but there were no differences after 8 min of exercise. In agreement with these findings, Howlett et al. (12) reported that muscle creatine phosphate utilization and lactate accumulation after 2 min of submaximal exercise were reduced after pretreatment with DCA. On the other hand, Parolin et al. (17) reported that, under hypoxic conditions, DCA infusion did not affect muscle creatine phosphate utilization during the 1st min of exercise, whereas muscle creatine phosphate was higher and muscle lactate was lower after 15 min of exercise than in a control situation. The precise explanation for these observations is not clear, since DCA exerts a complex myriad of effects in numerous tissues (for review see Ref. 21 ). It has been hypothesized that, by activating PDH and elevating the level of muscle acetyl-CoA and acetylcarnitine, DCA increases the availability of substrate for the TCA cycle and, thereby, increases the rate of mitochondrial respiration after onset of exercise (23). It has also been suggested that DCA might function to expand the pool of TCA cycle intermediates (TCAI) in resting skeletal muscle and, therefore, augment TCA cycle flux on contraction. However, it was recently shown that DCA actually lowers the total concentration of muscle TCAI at rest and does not alter the steady-state concentration of TCAI during exercise (8) .
In contrast to some of the studies cited above, we did not observe any differences between trials in creatine phosphate degradation or lactate accumulation during exercise. At first glance, the mean values for muscle creatine phosphate and lactate (Table 1 ) might indicate that the anaerobic energy production was (nonsignificantly) lower during the first 15 s in the DCA than in the Con trial, but this difference was largely due to one subject who had a markedly higher anaerobic energy production in Con (Fig. 8) . The difference in anaerobic energy production calculated from average values would have corresponded to a difference in O 2 uptake and O 2 extraction of ϳ125 ml/min and 50 ml/l, respectively, between Con and DCA. These differences are far above the detection limit of the method, since a significant difference in O 2 extraction of 20 ml/l has been observed when intense exercise was repeated (4) .
The extent of PDH activation after DCA administration in the present study was greater than that reported by Timmons and co-workers (22, 23) and smaller than that found by Howlett et al. (12) , so this appears not to be the reason for the different findings. A more likely explanation is the difference in the intensity of the muscle contractions between the present study and several other studies in which submaximal workloads were employed (12, 22) . In support of this suggestion, Howlett et al. (13) did not observe any effect of DCA infusion on muscle phosphocreatine degradation and lactate accumulation during 10 s of maximal cycling. It should also be considered that the lower muscle lactate concentration observed in mixed muscle biopsies during submaximal exercise after DCA infusion (12, 22, 23) may not be solely due to an enhanced rate of pyruvate oxidation. Lactate release was not measured in these previous studies; however, in the present study, we observed a higher rate of lactate release after 30 s of exercise after DCA administration. Moreover, during submaximal exercise, not all the muscle fibers may be activated, and the elevated activity of PDH in the inactive and partly active muscle fibers in the contracting muscles may have led to a greater conversion of lactate to pyruvate subsequent to an elevated rate of pyruvate oxidation. This hypothesis is supported by the observation that muscle lactate was not lowered after 30 s, but after 2 min of exercise in the study by Howlett et al. (12) , indicating that removal of lactate, rather than production of lactate, was influenced. Although the present findings do not rule out the importance of PDH activation and/or acetyl group availability in determining muscle O 2 utilization at the start of submaximal exercise, these factors do not appear to be important in regulating muscle respiration and anaerobic metabolism during the initial phase of intense contraction. As recognized by Howlett and colleagues (13), there could be a limit to oxidative metabolism within the muscle at sites other than PDH, such as the TCA cycle or the electron transport chain.
In summary, the present findings demonstrate that DCA infusion increased PDH a at rest and during the initial phase of intense exercise but did not alter muscle O 2 uptake, creatine phosphate utilization, or muscle lactate production. These data suggest that the activation state of PDH is not limiting for muscle O 2 utilization during the first phase of intense dynamic exercise (ϳ110% of V O 2 peak ) in humans.
Perspectives
The workload for this study was selected to ensure that muscle activation was complete, that muscle O 2 demand was high, and also that pyruvate-derived acetyl-CoA was the primary fuel source for mitochondrial respiration. Our findings indicate that the rate of PDH activation does not limit muscle O 2 uptake during the initial phase of intense dynamic exercise in humans. Evidence has also been presented to suggest that, under these conditions, muscle O 2 uptake is not limited by O 2 delivery. Thus, if it is assumed that the delay resides within the muscle, future studies should examine the citric acid cycle and electron transport chain for potential sites of limitation to muscle O 2 uptake during the initial phase of contraction.
